Log in to save to my catalogue

Vitamin B 12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and c...

Vitamin B 12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_30858560

Vitamin B 12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

About this item

Full title

Vitamin B 12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

Publisher

England

Journal title

Cell research, 2019-04, Vol.29 (4), p.313

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

Missense mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) cause the majority of familial and some sporadic forms of Parkinson's disease (PD). The hyperactivity of LRRK2 kinase induced by the pathogenic mutations underlies neurotoxicity, promoting the development of LRRK2 kinase inhibitors as therapeutics. Many potent and specific small-molecule LR...

Alternative Titles

Full title

Vitamin B 12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_30858560

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_30858560

Other Identifiers

E-ISSN

1748-7838

DOI

10.1038/s41422-019-0153-8

How to access this item